Uterine Corpus Leiomyoma
1 clinical trials · Condition
◉ Watch Uterine Corpus Leiomyoma
| Record | Firm | Date |
|---|---|---|
| Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer (NCT07716735) | Jonsson Comprehensive Cancer Center | 2026-12-01 |
Track Uterine Corpus Leiomyoma automatically
Every clearance here is in the API, with alerts when new ones post.